Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Shields

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
JTO Clinical and Research Reports|September 30, 2021
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research AutopsyHui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, et al.
Oncoimmunology|February 21, 2025
Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patientsAnet Greib, Songzhu Zhao, Michelle Ploch, et al.
International Journal of Radiation Oncology, Biology, Physics|February 22, 2024
A Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung CancerTerence M Williams, Eric Miller, Meng Welliver, et al.
Breast Cancer Research : BCR|July 19, 2019
Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancerMustafa M Basree, Neelam Shinde, Christopher Koivisto, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-114: Association Between Neoadjuvant Chemoimmunotherapy-Induced Anemia and Survival in Patients With Resectable Non-Small Cell Lung CancerJennifer D Hwang, Po-Lan Su, Sonia Zhao, et al.
Clinical Lung Cancer|July 27, 2025
Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Nonsmall Cell Lung CancerJohn Sharp, Philip Young, Songzhu Zhao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-114: Association Between Neoadjuvant Chemoimmunotherapy-Induced Anemia and Survival in Patients With Resectable Non-Small Cell Lung CancerJennifer D Hwang, Po-Lan Su, Sonia Zhao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint InhibitorsNikhil Sekar, Songzhu Zhao, Alexander Rudich, et al.
International Journal of Cancer|February 21, 2003
CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controlsPaolo Vineis, Fabrizio Veglia, Simone Benhamou, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint InhibitorsNikhil Sekar, Songzhu Zhao, Alexander Rudich, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
JTO Clinical and Research Reports|September 30, 2021
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research AutopsyHui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, et al.
Oncoimmunology|February 21, 2025
Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patientsAnet Greib, Songzhu Zhao, Michelle Ploch, et al.
International Journal of Radiation Oncology, Biology, Physics|February 22, 2024
A Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung CancerTerence M Williams, Eric Miller, Meng Welliver, et al.
Breast Cancer Research : BCR|July 19, 2019
Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancerMustafa M Basree, Neelam Shinde, Christopher Koivisto, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-114: Association Between Neoadjuvant Chemoimmunotherapy-Induced Anemia and Survival in Patients With Resectable Non-Small Cell Lung CancerJennifer D Hwang, Po-Lan Su, Sonia Zhao, et al.
Clinical Lung Cancer|July 27, 2025
Brief Report: Central Nervous System Metastases After Chemoradiation Followed by Durvalumab for Unresectable Locally Advanced Nonsmall Cell Lung CancerJohn Sharp, Philip Young, Songzhu Zhao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-114: Association Between Neoadjuvant Chemoimmunotherapy-Induced Anemia and Survival in Patients With Resectable Non-Small Cell Lung CancerJennifer D Hwang, Po-Lan Su, Sonia Zhao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint InhibitorsNikhil Sekar, Songzhu Zhao, Alexander Rudich, et al.
International Journal of Cancer|February 21, 2003
CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controlsPaolo Vineis, Fabrizio Veglia, Simone Benhamou, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint InhibitorsNikhil Sekar, Songzhu Zhao, Alexander Rudich, et al.
Pageof 3